Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jet-injected dexmedetomidine for needle phobia sedation study
ACTRN12621000547842Phase 4Completed
- Sponsor
- Anaesthetic Research Department
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in trypanophobia and preoperative anxiety, sponsored by Anaesthetic Research Department. Primary endpoint: Plasma concentrations of dexmedetomidine. Started Dec 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
trypanophobiapreoperative anxiety
Beyond the preview
Go deeper on ACTRN12621000547842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000547842.